Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Minerva Med ; 106(5): 239-246, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26495821

RESUMO

AIM: Since the efficacy of antibiotics in the management of cough from upper respiratory tract infections (URTI) is unclear, we conducted an observational study to evaluate the efficacy of antibiotic compared to symptomatic treatment in adults with productive cough from URTI in a real life setting. METHODS: One-hundred and 50 subjects presenting to five general practice ambulatories with productive cough due to URTI were included in the study. According to the physician judgment, patients were treated with either oral antibiotics (group A, 50 patients), a mucoactive syrup (sobrerol: group S, 50 patients) as symptomatic treatment, or both sobrerol and oral antibiotics (group SA, 50 patients). Cough severity was assessed daily with a diary, by means of a validated verbal category-descriptive (VCD) Scale. RESULTS: In every treatment group cough severity decreased over time (P<0.001); however, during the first week of treatment patients in groups S and SA experienced significantly lower VCD score values in comparison to Group A (P=0.045 and P=0.010, respectively). On the other hand, the VCD score was never significantly different between the two groups that received symptomatic treatment at any of the 4 weeks of the study, suggesting that the effect observed was due to the action of the mucoactive syrup. CONCLUSION: Our data confirm the lack of efficacy of antibiotics in the management of productive cough in URTI and suggest that symptomatic treatment should be preferred to antibiotics in acute cough from URTI.

2.
Thorax ; 59(9): 769-72, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15333853

RESUMO

BACKGROUND: Iodo-resiniferatoxin (I-RTX) has recently been described as an ultra potent antagonist of the transient receptor potential vanilloid-1 (TRPV1). METHODS: The ability of I-RTX to inhibit cough induced by inhalation of two putative TRPV1 stimulants (capsaicin and citric acid) was tested in non-anaesthetised guinea pigs. RESULTS: Pretreatment with I-RTX either intraperitoneally (0.03-0.3 micromol/kg) or by aerosol (0.1-3 microM) reduced the number of coughs produced by inhalation of citric acid (0.25 M) and capsaicin (30 microM) in a dose dependent manner. Capsazepine (CPZ) also reduced citric acid and capsaicin induced cough, but the activity of I-RTX was 10-100 times more potent than CPZ in all the experimental conditions tested. CONCLUSIONS: I-RTX is a novel and potent antitussive drug which inhibits cough mediated by agents possibly acting via TRPV1 activation.


Assuntos
Antitussígenos/uso terapêutico , Tosse/prevenção & controle , Diterpenos/uso terapêutico , Canais Iônicos , Receptores de Droga/antagonistas & inibidores , Animais , Cobaias , Masculino , Canais de Cátion TRPV
3.
Nucl Med Commun ; 16(4): 258-64, 1995 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7624106

RESUMO

Single photon emission tomography (SPET) employing 99Tcm-sestamibi (MIBI) injected intravenously was performed in 27 patients for pre-surgical evaluation of intraparenchymal brain tumours. A computerized tomography (CT) scan was performed in 26 patients, magnetic resonance imaging (MRI) in 8 patients and digital subtraction angiography (DSA) in 14 patients. Visual analysis of the SPET scans was performed using a 4-point scale relating to background activity, to evaluate MIBI uptake in the tumour. The vascular supply and the cellular component were also evaluated using DSA and CT scans. In normal controls, MIBI uptake was observed in the scalp, in the choroid plexus and in the pituitary gland, but never in normal parenchyma. Among the astrocytoma group of patients, a trend between MIBI uptake and grade of tumour was noted. MIBI uptake in meningiomas depends primarily on the vascular supply. Our results support the hypothesis that vascular supply, integrity of the blood-brain barrier, the degree of malignancy of the neoplasm and the viability of the tumour cells may be related to MIBI uptake.


Assuntos
Neoplasias Encefálicas/diagnóstico por imagem , Tecnécio Tc 99m Sestamibi , Tomografia Computadorizada de Emissão de Fóton Único , Adulto , Idoso , Angiografia Digital , Astrocitoma/diagnóstico , Astrocitoma/diagnóstico por imagem , Neoplasias Encefálicas/diagnóstico , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/diagnóstico por imagem , Meningioma/diagnóstico , Meningioma/diagnóstico por imagem , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
4.
Clin Ter ; 136(4): 261-6, 1991 Feb 28.
Artigo em Italiano | MEDLINE | ID: mdl-1827388

RESUMO

Efficacy and tolerability of an antitussive drug, levodropropizine, in 21 adult patients with interstitial lung disorders was evaluated in this study. Levodropropizine dosage was 60 mg t.i.d. for four days of therapy. The authors evaluated the effectiveness of the antitussive therapy and, on the other hand, the tolerability of levodropropizine in these patients, monitoring PaO2, PaCO2 and pH values. The changes in cough frequency (34.1 +/- 5.6 20.4 +/- 5.4 mean +/- d.s. before and after treatment) and the overall efficacy judgment as reported by the doctor indicate a decrease in cough as confirmed by the significance of Kruskal-Wallis test (p less than 0.05). Furthermore the tolerability has been excellent, because the PaO2, PaCo2 ad pH values before and after treatment were unchanged (PaO2 mmHg: basal 71 +/- 16.6, after treatment 73.8 +/- 14.2; PaCO2 mmHg: basal 36.6 +/- 5, after treatment 36.6 +/- 4.6; pH basal 7.4 +/- 0.03, after treatment 7.4 +/- 0.02).


Assuntos
Antitussígenos/uso terapêutico , Pneumopatias/tratamento farmacológico , Propilenoglicóis/uso terapêutico , Fibrose Pulmonar/tratamento farmacológico , Sarcoidose/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Antitussígenos/administração & dosagem , Avaliação de Medicamentos , Tolerância a Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Propilenoglicóis/administração & dosagem
5.
Clin Ter ; 132(5): 321-8, 1990 Mar 15.
Artigo em Italiano | MEDLINE | ID: mdl-2139835

RESUMO

The authors evaluated the effect of an orally administered polymicrobial vaccine in a group of chronic bronchitis patients in order to assess its efficacy in preventing recurrent infections and as adjuvants during minor acute episodes. Compared to the control group, vaccinated patients had 1) a reduced number of flare-ups, and these were less severe and symptoms were improved; II) lymphocyte phenotype was not altered in any of the patients but nevertheless the response to skin tests for delayed sensitivity was improved in the vaccinated patients only; III) more rapid symptomatic improvement of flare-ups. The authors stress the improvement of cell-mediated lymphocyte function as a result of vaccination, probably due to macrophage activation and with resulting improvement of the clinical course of the bronchial disorder.


Assuntos
Vacinas Bacterianas/administração & dosagem , Bronquite/terapia , Haemophilus influenzae/imunologia , Staphylococcus aureus/imunologia , Streptococcus pneumoniae/imunologia , Streptococcus/imunologia , Adulto , Idoso , Vacinas Bacterianas/imunologia , Bronquite/imunologia , Humanos , Linfócitos/imunologia , Pessoa de Meia-Idade , Testes Cutâneos
6.
Radiol Med ; 75(6): 589-94, 1988 Jun.
Artigo em Italiano | MEDLINE | ID: mdl-3387610

RESUMO

Exogenous lipid pneumonia (ELP) is caused by the aspiration of animal, vegetal or, more often, mineral oils. Even though it may also be acute, ELP is most frequently a chronic disease, affecting people with predisposing factors, such as neuromuscular disorders, structural abnormalities and so on; very often exogenous lipid pneumonia is found in tracheotomized patients. The pathology of lipid pneumonia is a chronic inflammatory process evolving in foreign-body-like reaction, and eventually in "end-stage lung" condition. Clinically, most patients are asymptomatic; few cases only present with cough, dyspnea and chest pain. Eight cases of ELP, studied over the past 3 years, are described in this paper. All the patients were examined by chest radiographs and standard tomograms; 3 patients underwent CT. X-ray features were mono/bilateral consolidation of the lower zones, with air bronchogram and variable reduction in volume. CT density was not specific for fat tissue. In all cases the diagnosis was confirmed at biopsy. In 5 patients, followed for at least one year, clinical-radiological features showed no change. Thus, complications of ELP (especially malignant evolution) could be excluded. The authors conclude that lipid pneumonia must be considered in differential diagnosis of patients with history of usage of oils and compatible X-ray findings. The usefulness of an accurate follow-up is stressed.


Assuntos
Pneumonia Aspirativa/diagnóstico por imagem , Pneumonia Lipoide/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Adulto , Idoso , Estudos de Avaliação como Assunto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pneumonia Lipoide/etiologia , Pneumonia Lipoide/patologia
8.
Radiol Med ; 73(3): 162-5, 1987 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-3562913

RESUMO

The authors present their own experience in the diagnosis of thoracic adenopathies and mediastinal masses by transbronchial needle aspiration (Wang needle). The diagnostic usefulness and safety of the method is stressed. Radiology plays an important role in choosing biopsy site (by CT), in monitoring the procedure by fluoroscopy and looking for complications following completion of the examination.


Assuntos
Broncoscopia , Carcinoma/patologia , Doença de Hodgkin/patologia , Neoplasias do Mediastino/patologia , Idoso , Biópsia por Agulha , Carcinoma/diagnóstico por imagem , Feminino , Doença de Hodgkin/diagnóstico por imagem , Humanos , Masculino , Neoplasias do Mediastino/diagnóstico por imagem , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
9.
Boll Ist Sieroter Milan ; 66(3): 247-53, 1987.
Artigo em Italiano | MEDLINE | ID: mdl-3435656

RESUMO

The Authors report the results obtained within a multicentrical trial, weighing the immunostimolant effect of bacterial lysate on 157 patients. The drug (bacterial lysate) has induced an immunitary reaction, making significantly higher either the salivary IgA values or the serum IgA, IgG and IgM values. Also excellent tolerability is peculiar to this new immunostimolant.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Produtos Biológicos/uso terapêutico , Imunoglobulinas/metabolismo , Doenças Respiratórias/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Avaliação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Respiratórias/terapia , Saliva/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...